These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 5137628)

  • 1. A one-year follow-up on a rubella vaccine trial in health personnel.
    Snell E; Stackiw W; Wilt JC
    Can J Public Health; 1971; 62(5):448-9. PubMed ID: 5137628
    [No Abstract]   [Full Text] [Related]  

  • 2. Artificial challenge studies in rubella. Utilization of RA 27-3 rubella vaccines, rubella naturally acquired seropositives, and rubella susceptible children.
    Naficy K; Nategh R; Ahangary S; Mohsenin H
    Am J Dis Child; 1970 Dec; 120(6):520-3. PubMed ID: 5481902
    [No Abstract]   [Full Text] [Related]  

  • 3. Rubella virus vaccine (HPV-77-DE 5). Antigenic and protective efficacy in a community trial.
    McCollum RW; Randolph MF; Byrne EB; Hilleman MR
    Am J Dis Child; 1969 Aug; 118(2):186-9. PubMed ID: 4893821
    [No Abstract]   [Full Text] [Related]  

  • 4. A survey of rubella antibodies in health personnel and a report of vaccine trial.
    Snell E; Stackiw W; Wilt JC
    Can Med Assoc J; 1971 Feb; 104(3):206-9. PubMed ID: 5539728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus.
    Ogra PL; Kerr-Grant D; Umana G; Dzierba J; Weintraub D
    N Engl J Med; 1971 Dec; 285(24):1333-9. PubMed ID: 4107718
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunity and anti-rubella vaccination].
    Delville JP; Tellini-Emma M
    Arch Belg Med Soc; 1970 May; 28(5):321-30. PubMed ID: 5494764
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative studies of rubella vaccines.
    Karchmer AW; Herrmann KL; Friedman JP; Shope TC; Page EE; Dressler MS; Armes WH; Witte JJ
    Am J Dis Child; 1969 Aug; 118(2):197-202. PubMed ID: 5794814
    [No Abstract]   [Full Text] [Related]  

  • 8. Attenuated rubella vaccine (HPV-77): evaluation in a large controlled trial.
    Lipman RP; Bethel MB; Wooten JH; Levine RH; Pagano JS
    Am J Public Health; 1971 Jul; 61(7):1392-402. PubMed ID: 4935166
    [No Abstract]   [Full Text] [Related]  

  • 9. [A comparative evaluation of the immunogenic activity of attenuated strains of rubella virus from the USA, Belgium and the USSR].
    Nifontova AI; Meshalova VN; Iakovleva NV; Smorodintsev AA
    Vopr Virusol; 1970; 15(6):711-4. PubMed ID: 5518646
    [No Abstract]   [Full Text] [Related]  

  • 10. An open community trial of live rubella vaccines. Study of vaccine virus transmissibility and antigenic efficacy of three HPV-77 derivatives.
    Veronelli JA
    JAMA; 1970 Sep; 213(11):1829-36. PubMed ID: 4917635
    [No Abstract]   [Full Text] [Related]  

  • 11. Exposure of susceptible pregnant women to rubella vaccinees. Serologic findings during the Rhode Island immunization campaign.
    Scott HD; Byrne EB
    JAMA; 1971 Jan; 215(4):609-12. PubMed ID: 5107437
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibody response to rubella virion (V) and soluble (S) antigens in rubella infection and following vaccination with live attenuated rubella virus.
    Vesikari T; Vaheri A; Leinikki P
    Arch Gesamte Virusforsch; 1971; 35(1):25-37. PubMed ID: 4943281
    [No Abstract]   [Full Text] [Related]  

  • 13. Loss of rubella hemagglutination inhibition antibody in congenital rubella. Failure of seronegative children with congenital rubella to respond to HPV-77 rubella vaccine.
    Cooper LZ; Florman AL; Ziring PR; Krugman S
    Am J Dis Child; 1971 Nov; 122(5):397-403. PubMed ID: 5129528
    [No Abstract]   [Full Text] [Related]  

  • 14. Epidemiological implications of rubella "vaccine failures".
    Wilkins J; Leedom JM; Portnoy B; Salvatore MA
    Am J Dis Child; 1972 Jan; 123(1):31-3. PubMed ID: 5010549
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental active and passive immunization against rubella.
    Budai J; Tóth M; Melis L
    Acta Paediatr Acad Sci Hung; 1970; 11(3):209-17. PubMed ID: 4111953
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical manifestations, according to age, among females given HPV-77 duck rubella vaccine.
    Swartz TA; Klingberg W; Goldwasser RA; Klingberg MA; Goldblum N; Hilleman MR
    Am J Epidemiol; 1971 Sep; 94(3):246-51. PubMed ID: 5093654
    [No Abstract]   [Full Text] [Related]  

  • 17. Rubella vaccination in adult females.
    Weibel RE; Stokes J; Buynak EB; Hilleman MR
    N Engl J Med; 1969 Mar; 280(13):682-5. PubMed ID: 5250184
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined live rubella-mumps virus vaccine. Findings in clinical-laboratory studies.
    Weibel RE; Stokes J; Villarejos VM; Arguedas JA; Buynak EB; Hilleman MR
    JAMA; 1971 May; 216(6):983-6. PubMed ID: 5108387
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparative field evaluation of three live, attenuated rubella virus vaccines.
    Kehrer AF; Isacson P
    Am J Public Health; 1971 Jan; 61(1):152-6. PubMed ID: 5539842
    [No Abstract]   [Full Text] [Related]  

  • 20. [Trials of vaccination against rubella with the Cendehill C-51 strain of live and attenuated virus].
    Fara GM; Galli MG; Nodari R; Saccani CF; Marangoni L; Bozzetti A; Tarantino F
    Minerva Med; 1970 Apr; 61(30 Suppl):1574-7. PubMed ID: 5439721
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.